Radioprotection: The non-steroidal anti-inflammatory drugs (NSAIDs) and prostaglandins

Journal of Pharmacy and Pharmacology

Volumn 54, Issue 11, 2002, Pages 1435-1445

  Lee, Tat Khuen ^a   Stupans, Ieva ^a  

^a UNIVERSITY OF SOUTH AUSTRALIA   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ARACHIDONIC ACID; BASIC FIBROBLAST GROWTH FACTOR; CERAMIDE; CYCLOOXYGENASE 1; CYTOKINE; HEAT SHOCK PROTEIN; ICOSANOID; INDOMETACIN; INTERLEUKIN 1BETA; MISOPROSTOL; NAPROXEN; NONSTEROID ANTIINFLAMMATORY AGENT; PIROXICAM; PROSTAGLANDIN; PROSTAGLANDIN E1 DERIVATIVE; PROSTAGLANDIN E2; PROSTAGLANDIN SYNTHASE; PROTEIN P53; SULINDAC SULFIDE; SUPEROXIDE DISMUTASE; TUMOR NECROSIS FACTOR ALPHA; ANTINEOPLASTIC AGENT; PROSTAGLANDIN SYNTHASE INHIBITOR; RADIOPROTECTIVE AGENT;

ANGIOGENESIS; ANTINEOPLASTIC ACTIVITY; APOPTOSIS; CANCER; CANCER CELL; CANCER RADIOTHERAPY; CANCER TISSUE; CELL CYCLE G0 PHASE; CELL CYCLE G1 PHASE; CELL CYCLE G2 PHASE; CELL CYCLE S PHASE; CELL DIFFERENTIATION; CELL GROWTH; CELL KINETICS; CELL LEVEL; CELL PROLIFERATION; CELL SURVIVAL; CLINICAL TRIAL; COMPARATIVE STUDY; DNA DAMAGE; DOSE RESPONSE; DRUG CYTOTOXICITY; DRUG EXPOSURE; DRUG MECHANISM; GASTROINTESTINAL SYMPTOM; GENE EXPRESSION; GROWTH INHIBITION; HUMAN; IN VIVO STUDY; IRRADIATION; KIDNEY DISEASE; MITOSIS; MITOSIS INHIBITION; NONHUMAN; NUTRIENT SUPPLY; OXIDATIVE PHOSPHORYLATION; OXYGEN SUPPLY; PROSPECTIVE STUDY; PROSTAGLANDIN BLOOD LEVEL; RADIATION EXPOSURE; RADIATION INJURY; RADIATION PNEUMONIA; RADIATION PROTECTION; RADIATION RESPONSE; RADIOSENSITIVITY; REVIEW; TISSUE INJURY; ANIMAL; BIOSYNTHESIS; CELL CYCLE; DRUG EFFECT; METABOLISM; NEOPLASM; PATHOLOGY; RADIOTHERAPY;

ANIMALS; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; ANTINEOPLASTIC AGENTS; APOPTOSIS; CELL CYCLE; CLINICAL TRIALS; CYCLOOXYGENASE INHIBITORS; DNA DAMAGE; EICOSANOIDS; GENE EXPRESSION; HUMANS; NEOPLASMS; PROSTAGLANDINS; RADIATION INJURIES; RADIATION-PROTECTIVE AGENTS; RADIOTHERAPY; TUMOR SUPPRESSOR PROTEIN P53;

EID: 0036847879     PISSN: 00223573     EISSN: None     Source Type: Journal    
DOI: 10.1211/00223570254     Document Type: Review

References (116)

1. Alberts, D.S., Hixson, L., Ahnen, D., Bogert, C., Einspahr, J., Paranka, N., Brendel, K., Gross, P.H., Pamukcu, R., Burt, R.W. (1995) Do NSAIDs exert their colon cancer chemoprevention activities through the inhibition of mucosal prostaglandin synthetase? J. Cell Biochem. 22 (Suppl.): 18-23
2. Baker, D.G., Krochak, R.J. (1989) The response of the microvascular system to radiation: a review. Cancer Invest. 7: 287-294.
3. Bamba, H., Ota, S., Kato, A., Matsuzaki, F. (1998) Nonsteroidal anti-inflammatory drugs may delay the repair of gastric mucosa by suppressing prostaglandin-mediated increase of hepatocyte growth factor production. Biochem. Biophys. Res. Commun. 245: 567-571
4. Bamba, H., Ota, S., Kato, A., Kawamoto, C., Fujiwara, K. (2000) Prostaglandins up-regulate vascular endothelial growth factor production through distinct pathways in differentiated U937 cells. Biochem. Biophys. Res. Commun. 273, 485-491
5. Banan, A., Smith, G.S., Kokoska, E.R., Miller, T.A. (2000) Role of actin cytoskeleton in prostaglandin-induced protection against ethanol in an intestinal epithelial cell line. J. Surg. Res. 88: 104-113
6. Bayer, B.M., Beaven, M.A. (1979) Evidence that indomethacin reversibly inhibits cell growth in the G1 phase of the cell cycle. Biochem. Pharmacol. 28: 441-443
7. Bayer, B.M., Kruth, H.S., Vaughan, M., Beaven, M.A. (1979) Arrest of cultured cells in the G1 phase of the cell cycle by indomethacin. J. Pharmacol. Exp. Ther. 210: 106-111
8. Ben-Av, P., Crofford, L.J., Wilder, R.L., Hla, T. (1995) Induction of vascular endothelial growth factor expression in synovial fibroblasts by prostaglandin E and interleukin-1: a potential mechanism for inflammatory angiogenesis. FEBS Lett. 372: 83-87
9. Bernhard, E.J., McKenna, W.G., Muschel, R.J. (1999) Radiosensitivity and the cell cycle. Cancer J. Sci. Am. 5: 194-204
10. Birnboim, H.C. (1982) DNA strand breakage in human leukocytes exposed to a tumor promoter, phorbol myristate acetate. Science 215: 1247-1249
11. Birnboim, H.C., Kanabus-Kaminska, M. (1985) The production of DNA strand breaks in human leukocytes by superoxide anion may involve a metabolic process. Proc. Natl Acad. Sci. USA 82: 6820-6824
12. Bishop-Bailey, D., Burke-Gaffney, A., Hellewell, P.G., Pepper, J.R., Mitchell, J.A. (1998) Cyclo-oxygenase-2 regulates inducible ICAM-1 and VCAM-1 expression in human vascular smooth muscle cells. Biochem. Biophys. Res. Commun. 249: 44-47
13. Bloomer, W.D., Hellman, S. (1975) Normal tissue responses to radiation therapy. N. Engl. J. Med. 293: 80-83
14. Bode, A.M., Dong, Z. (2000) Signal transduction pathways: targets for chemoprevention of skin cancer. Lancet Oncol. 1: 181-188
15. Borish, L., Rosenwasser, L.J. (1996) Update on cytokines. J. Allergy Clin. Immunol. 97: 719-733
16. Bray, F., Sankila, R., Ferlay, J., Parkin, D.M. (2002) Estimates of cancer incidence and mortality in Europe in 1995. Eur. J. Cancer 38: 99-166
17. Brown, L.F., Berse, B., Jackman, R.W., Tognazzi, K., Manseau, E.J., Senger, D.R., Dvorak, H.F. (1993) Expression of vascular permeability factor (vascular endothelial growth factor) and its receptors in adenocarcinomas of the gastrointestinal tract. Cancer Res. 53: 4727-4735
18. Burkey, T.H., Regan, J.W. (1995) Activation of mitogen-activated protein kinase by the human prostaglandin EP3A receptor. Biochem. Biophys. Res. Commun. 211: 152-158
19. Chan, T.A., Morin, P.J., Vogelstein, B., Kinzler, K.W. (1998) Mechanisms underlying nonsteroidal antiinflammatory drug-mediated apoptosis. Proc. Natl Acad. Sci. USA 95: 681-686
20. Chang, C.M.; Limanni, A., Baker, W.H., Dobson, M.E., Kalinich, J.F., Patchen, M.L. (1997) Sublethal gamma irradiation increases IL-1alpha, IL-6, and TNF-alpha mRNA levels in murine hematopoietic tissues. J. Interferon Cytokine Res. 17: 567-572
21. Chernecky, C., Sarna, L. (2000) Pulmonary toxicities of cancer therapy. Crit. Care Nurs. Clin. North Am. 12: 281-295
22. Cherny, N.I. (2001) The pharmacological management of cancer pain. Eur. J. Cancer 37: S265-S278
23. Coleman, C.N. (2002) Radiation oncology - linking technology and biology in the treatment of cancer. Acta Oncol. 41: 6-13
24. Coleman, R.A., Grix, S.P., Head, S.A., Louttit, J.B., Mallett, A., Sheldrick, R.L. (1994) A novel inhibitory prostanoid receptor in piglet saphenous vein. Prostaglandins 47: 151-168
25. Das, U. (2002) A radical approach to cancer. Med. Sci. Monit. 8 RA79-R92
26. Dermond, O., Ruegg, C. (2001) Inhibition of tumor angiogenesis by non-steroidal anti-inflammatory drugs: emerging mechanisms and therapeutic perspectives. Drug Resist. Updat. 4: 314-321
27. Diaz, A., Chepenik, K.P., Korn, J.H., Reginato, A.M., Jimenez, S.A. (1998) Differential regulation of cyclooxygenases 1 and 2 by interleukin-1 beta, tumor necrosis factor-alpha, and transforming growth factor-beta 1 in human lung fibroblasts. Exp. Cell Res. 241: 222-229
28. Duenas-Gonzalez, A., Sobrevilla-Calvo, P., Frias-Mendivil, M., Gallardo-Rincon, D., Lara-Medina, F., Aguilar-Ponce, L., Miranda-Lopez, E., Zinser-Sierra, J., Reynoso-Gomez, E. Misoprostol prophylaxis for high-dose chemotherapy-induced mucositis: a randomized double-blind study. (1996) Bone Marrow Transplant 17: 809-812
29. Ebert, M.A. (1997) Optimisation in radiotherapy I: defining the problem. Australas. Phys. Eng. Sci. Med. 20: 164-176
30. Fedorocko, P., Mackova, N.O. (1996a) Combined modality radioprotection: enhancement of survival and hematopoietic recovery in gamma-irradiated mice by the joint use of liposomal muramyl tripeptide phosphatidylethanolamine (MTP-PE) and indomethacin. Int. J. Immunopharmacol. 18: 329-337
31. Fedorocko, P., Mackova, O. (1996b) Radioprotective effects of combination broncho-vaxom, a macrophage activator, and indomethacin, an inhibitor of prostaglandin production: relationship to myelopoiesis. Eur. J. Haematol. 56: 54-61
32. Fedorocko, P., Egyed, A., Vacek, A. (2002) Irradiation induces increased production of haemopoietic and proinflammatory cytokines in the mouse lung. Int. J. Radiat. Biol. 78: 305-313
33. Ford, H.L., Pardee, A.B. (1999) Cancer and the cell cycle. J. Cell Biochem. 32-22 (Suppl.): 166-172
34. Fuks, Z., Persaud, R.S., Alfieri, A., McLoughlin, M., Ehleiter, D., Schwartz, J.L., Seddon, A.P., Cordon-Cardo, C., Haimovitz-Friedman, A. (1994) Basic fibroblast growth factor protects endothelial cells against radiation-induced programmed cell death in vitro and in vivo. Cancer Res. 54: 2582-2590
35. Furuta, Y., Hunter, N., Barkley, T., Hall, E., Milas, L. (1988) Increase in radioresponse of murine tumors by treatment with indomethacin. Cancer Res. 48: 3008-3013
36. Gamble, S.C., Dunn, M.J., Wheeler, C.H., Joiner, M.C., Adu-Poku, A., Arrand, J.E. (2000) Expression of proteins coincident with inducible radioprotection in human lung epithelial cells. Cancer Res. 60: 2146-2151
37. Gerstle, J.T., Seaton, J., Kauffman, G.L., Colony, P.C. (1994) The association between PGE2 activity and mucosal permeability in proximal small bowel. J. Surg. Res. 57: 579-583
38. Goldberg, R.I. (1986) Protection of irradiated parotid by prostaglandin synthesis inhibitors. J. Am. Dent. Assoc. 112: 179-181
39. Gonzalez-Flecha, B., Demple, B. (2000) Genetic responses to free radicals. Homeostasis and gene control. Ann. NY Acad. Sci. 899: 69-87
40. Gotz, C., Montenarh, M. (1996) p53: DNA damage, DNA repair, and apoptosis. Rev. Physiol. Biochem. Pharmacol. 127: 65-95
41. Grant, S., Dent, P. (2001) Overview: rational integration of agents directed at novel therapeutic targets into combination chemotherapeutic regimens. Curr. Opin. Invest. Drugs 2: 1600-1605
42. Granville, D.J., Carthy, C.M., Hunt, D.W., McManus, B.M. (1998) Apoptosis: molecular aspects of cell death and disease. Lab. Invest. 78: 893-913
43. Grosovsky, A.J. (1999) Radiation-induced mutations in unirradiated DNA. Proc. Natl Acad. Sci. USA 96: 5346-5347
44. Grosovsky, A.J., Parks, K.K., Giver, C.R., Nelson, S.L. (1996) Clonal analysis of delayed karyotypic abnormalities and gene mutations in radiation-induced genetic instability. Mol. Cell Biol. 16: 6252-6262
45. Haimovitz-Friedman, A., Balaban, N., McLoughlin, M., Ehleiter, D., Michaeli, J., Vlodavsky, I., Fuks, Z. (1994) Protein kinase C mediates basic fibroblast growth factor protection of endothelial cells against radiation-induced apoptosis. Cancer Res. 54: 2591-2597
46. Hallahan, D.E., Sukhatme, V.P., Sherman, M.L., Virudachalam, S., Kufe, D., Weichselbaum, R.R. (1991) Protein kinase C mediates x-ray inducibility of nuclear signal transducers EGR1 and JUN. Proc. Natl Acad. Sci. USA 88: 2156-2160
47. Hanif, R., Pittas, A., Feng, Y., Koutsos, M.I., Qiao, L., Staiano-Coico, L., Shiff, S.I., Rigas, B. (1996) Effects of nonsteroidal anti-inflammatory drugs on proliferation and on induction of apoptosis in colon cancer cells by a prostaglandin-independent pathway. Biochem. Pharmacol. 52: 237-245
48. Hanson, W.R. (1987) Radiation protection of murine intestine by WR-2721, 16,16-dimethyl prostaglandin E2, and the combination of both agents. Radiat. Res. 111: 361-373
49. Hanson, W. R., DeLaurentiis, K. (1987) Comparison of in vivo murine intestinal radiation protection by E-prostaglandins. Prostaglandins 33 (Suppl.): 93-104
50. Hanson, W. R., Thomas, C. (1983) 16, 16-dimethyl prostaglandin E2 increases survival of murine intestinal stem cells when given before photon radiation. Radiat. Res. 96: 393-398
51. Hanson, W. R., Houseman, K. A., Collins, P. W. (1988) Radiation protection in vivo by prostaglandins and related compounds of the arachidonic acid cascade. Pharmacol. Ther. 39: 347-356
52. Hanson, W. R., Marks, J. E., Reddy, S. P., Simon, S., Mihalo, W. E., Tova, Y. (1997) Protection from radiation-induced oral mucositis by a mouth rinse containing the prostaglandin E1 analog, misoprostol: a placebo controlled double blind clinical trial. Adv. Exp. Med. Biol. 400B: 811-818
53. Harada, S., Nagy, J. A., Sullivan, K. A., Thomas, K. A., Endo, N., Rodan, G. A., Rodan, S. B. (1994) Induction of vascular endothelial growth factor expression by prostaglandin E2 and E1 in osteoblasts. J. Clin. Invest. 93: 2490-2496
54. Hinz, B., Brune, K., Pahl, A. (2000) Prostaglandin E(2) upregulates cyclooxygenase-2 expression in lipopolysaccharide-stimulated RAW 264.7 macrophages. Biochem. Biophys. Res. Commun. 272: 744-748
55. Holbrook, N. J., Liu, Y., Fornace, A. J. (1996) Signaling events controlling the molecular response to genotoxic stress. Exs 77: 273-288
56. Honn, K. V., Busse, W. D., Sloane, B. F. (1983) Prostacyclin and thromboxanes. Implications for their role in tumor cell metastasis. Biochem. Pharmacol. 32: 1-11
57. Housby, J. N., Cahill, C. M., Chu, B., Prevelige, R., Bickford, K., Stevenson, M. A., Calderwood, S. K. (1999) Non-steroidal anti-inflammatory drugs inhibit the expression of cytokines and induce HSP70 in human monocytes. Cytokine 11: 347-358
58. Husain, S. S., Szabo, I. L., Tamawaski, A. S. (2002) NSAID inhibition of GI cancer growth: clinical implications and molecular mechanisms of action. Am. J. Gastroenterol. 97: 542-553
59. Kambayashi, T., Jacob, C. O., Zhou, D., Mazurek, N., Fong, M., Strassmann, G. (1995) Cyclic nucleotide phosphodiesterase type IV participates in the regulation of IL-10 and in the subsequent inhibition of TNF-alpha and IL-6 release by endotoxin-stimulated macrophages. J. Immunol. 155: 4909-4916
60. Kaplan, A. P., Joseph, K., Silverberg, M. (2002) Pathways for bradykinin formation and inflammatory disease. J. Allergy Clin. Immunol. 109: 195-209
61. Katsuyama, M., Ikegami, R., Karahashi, H, Amano, F., Sugimoto, Y., Ichikawa, A. (1998) Characterization of the LPS-stimulated expression of EP2 and EP4 prostaglandin E receptors in mouse macrophage-like cell line, J774.1. Biochem. Biophys. Res. Commun. 251: 727-731
62. Khan, A. M., Birk, J. W., Anderson, J. C., Georgsson, M., Park, T. L., Smith, C. J., Comer, G. M. (2000) A prospective randomized placebo-controlled double-blinded pilot study of misoprostol rectal suppositories in the prevention of acute and chronic radiation proctitis symptoms in prostate cancer patients. Am. J. Gastroenterol. 95: 1961-1966
63. Kimura, H., Minakami, H., Otsuki, K., Shoji, A. (2000) Cu-Zn superoxide dismutase inhibits lactate dehydrogenase release and protects against cell death in murine fibroblasts pretreated with ultraviolet radiation. Cell. Biol. Int. 24: 459-465
64. Knudsen, P. J., Dinarello, C. A., Strom, T. B. (1986) Prostaglandins posttranscriptionally inhibit monocyte expression of interleukin 1 activity by increasing intracellular cyclic adenosine monophosphate. J. Immunol. 137: 3189-3194
65. Komarova, E. A., Gudkov, A. V. (2001) Chemoprotection from p53-dependent apoptosis: potential clinical applications of the p53 inhibitors. Biochem. Pharmacol. 62: 657-667
66. Kontogiorgis, C. A., Hadjipavlou-Litina, D. J. (2002) Non steroidal anti-inflammatory and anti-allergy agents. Curr. Med. Chem. 9: 89-98
67. Koukourakis, M. (2002) Amifostine in clinical oncology: current use and future applications. Anticancer Drugs 13: 181-209
68. Kozubik, A., Hofmanova, J., Hola, J., Netikova, J. (1993) The effect of nordihydroguaiaretic acid, an inhibitor of prostaglandin and leukotriene biosynthesis, on hematopoiesis of gamma-irradiated mice. Exp. Hematol. 21: 138-142
69. Kozubik, A., Hofmanova, J., Pospisil, M., Netikova, J., Hola, J., Lojek, A. (1994) Effects of drugs inhibiting prostaglandin or leukotriene biosynthesis on postirradiation haematopoiesis in mouse. Int. J. Radiat. Biol. 65: 369-377
70. Labar, B., Mrsic, M., Pavletic, Z., Bogdanic, V., Nemet, D., Aurer, I., Radman, I., Filipovic-Grcic, N., Sertic, D., Kalenic, S., Presecki, V. (1993) Prostaglandin E2 for prophylaxis of oral mucositis following BMT. Bone Marrow Transplant. 11: 379-382
71. Little, M. P. (2001) Cancer after exposure to radiation in the course of treatment for benign and malignant disease. Lancet Oncol. 2: 212-220
72. Marnett, L. J., Rowlinson, S. W., Goodwin, D. C., Kalgutkar, A. S., Lanzo, C. A. (1999) Arachidonic acid oxygenation by COX-1 and COX-2. Mechanisms of catalysis and inhibition. J. Biol. Chem. 274: 22903-22906
73. Martin, M., Vozenin, M. C., Gault, N., Crechet, F., Pfarr, C. M., Lefaix, J. L. (1997) Coactivation of AP-1 activity and TGF-beta1 gene expression in the stress response of normal skin cells to ionizing radiation. Oncogene 15: 981-989
74. Mathes, S. J., Alexander, J. (1996) Radiation injury. Surg. Oncol. Clin. North Am. 5: 809-824
75. Matsumoto, H., Naraba, H., Murakami, M., Kudo, I., Yamaki, K., Ueno, A., Oh-ishi, S. (1997) Concordant induction of prostaglandin E2 synthase with cyclooxygenase-2 leads to preferred production of prostaglandin E2 over thromboxane and prostaglandin D2 in lipopolysaccharide-stimulated rat peritoneal macrophages. Biochem. Biophys. Res. Commun. 230: 110-114
76. Mazeron, J. J., Noel, G., Simon, J. M. (2002) Head and neck brachytherapy. Semin. Radiat. Oncol. 12: 95-108
77. Mercer, D. W., Ritchie, W. P., Dempsey, D. T. (1996) Effects of polyunsaturated fatty acids on bile acid-induced gastric mucosal injury. J. Surg. Res. 61: 44-50
78. Michels, A. A., Kanon, B., Konings, A. W., Ohtsuka, K., Bensaude, O., Kampinga, H. H. (1997) Hsp70 and Hsp40 chaperone activities in the cytoplasm and the nucleus of mammalian cells. J. Biol. Chem. 272: 33283-33289
79. Mingatto, F. E., Santos, A. C., Uyemura, S. A., Jordani, M. C., Curti, C. (1996) In vitro interaction of nonsteroidal anti-inflammatory drugs on oxidative phosphorylation of rat kidney mitochondria: respiration and ATP synthesis. Arch. Biochem. Biophys. 334: 303-308
80. Mitchell, J. B., Russo, A., Kuppusamy, P., Krishna, M. C. (2000) Radiation, radicals, and images. Ann. NY Acad. Sci. 899: 28-43
81. Morgan, D. O. (1995) Principles of CDK regulation. Nature 374: 131-134
82. Morris, G. M. (1996) Review article: effects of radiation on the cell proliferation kinetics of epithelial tissues - therapeutic implications. Br. J. Radiol. 69: 795-803
83. Nivsarkar, M. (2000) Improvement in circulating superoxide dismutase levels: role of nonsteroidal anti-inflammatory drugs in rheumatoid arthritis. Biochem. Biophys. Res. Commun. 270: 714-716
84. Northway, M. G., Libshitz, H. I., Osborne, B. M., Feldman, M. S., Mamel, J. J., West, J. H., Szwarc, I. A. (1980) Radiation esophagitis in the opossum: radioprotection with indomethacin. Gastroenterology 78: 883-892
85. Ohanian, J., Ohanian, V. (2001) Sphingolipids in mammalian cell signalling. Cell Mol. Life Sci. 58: 2053-2068
86. Pai, R., Szabo, I. L., Kawanaka, H., Soreghan, B. A., Jones, M. K., Tarnawski, A. S. (2000) Indomethacin inhibits endothelial cell proliferation by suppressing cell cycle proteins and PRB phosphorylation: a key to its antiangiogenic action? Mol. Cell Biol. Res. Commun. 4: 111-116
87. Palayoor, S. T., Bump, E. A., Calderwood, S. K., Bartol, S., Coleman, C. N. (1998) Combined antitumor effect of radiation and ibuprofen in human prostate carcinoma cells. Clin. Cancer Res. 4: 763-771
88. Perugini, R. A., McDade, T. P., Vittimberga, F. J., Duffy, A. J., Callery, M. P. (2000) Sodium salicylate inhibits proliferation and induces G1 cell cycle arrest in human pancreatic cancer cell lines. J. Gastrointest. Surg. 4: 24-32
89. Peter, M., Herskowitz, I. (1994) Joining the complex: cyclin-dependent kinase inhibitory proteins and the cell cycle. Cell 79: 181-184
90. Pillsbury, H. C., Webster, W. P., Rosenman, J. (1986) Prostaglandin inhibitor and radiotherapy in advanced head and neck cancers. Arch. Otolaryngol. Head Neck Surg. 112: 552-553
91. Prasad, K. N. (1972) Radioprotective effect of prostaglandin and an inhibitor of cyclic nucleotide phosphodiesterase on mammalian cells in culture. Int. J. Radiat. Biol. Relat. Stud. Phys. Chem. Med. 22: 187-189
92. Rahman, M. A., Dhar, D. K., Masunaga, R., Yamanoi, A., Kohno, H., Nagasue, N. (2000) Sulindac and exisulind exhibit a significant antiproliferative effect and induce apoptosis in human hepato-cellular carcinoma cell lines. Cancer Res. 60: 2085-2089
93. Renz, H., Gong, J. H., Schmidt, A., Nain, M., Gemsa, D. (1988) Release of tumor necrosis factor-alpha from macrophages. Enhancement and suppression are dose-dependently regulated by prostaglandin E2 and cyclic nucleotides. J. Immunol. 141: 2388-2393
94. Resnitzky, D., Gossen, M., Bujard, H., Reed, S. I. (1994) Acceleration of the G1/S phase transition by expression of cyclins D1 and E with an inducible system. Mol. Cell Biol. 14: 1669-1679
95. Rigas, B., Goldman, I. S., Levine, L. (1993) Altered eicosanoid levels in human colon cancer. J. Lab. Clin. Med. 122: 518-523
96. Simon, M. M., Reikerstorfer, A., Schwarz, A., Krone, C., Luger, T. A., Jattela, M., Schwarz, T. (1995) Heat shock protein 70 overexpression affects the response to ultraviolet light in murine fibroblasts. Evidence for increased cell viability and suppression of cytokine release. J. Clin. Invest. 95: 926-933
97. Skopinska-Rozewska, E., Piazza, G. A.; Sommer, E., Pamukcu, R., Barcz, E., Filewska, M., Kupis, W., Caban, R., Rudzinski, P., Bodgan, J., Mlekodaj, S., Sikorska, E. (1998) Inhibition of angiogenesis by sulindac and its sulfone metabolite (FGN-1): a potential mechanism for their antineoplastic properties. Int. J. Tissue React. 20: 85-89
98. Slingerland, J., Pagano, M. (2000) Regulation of the cdk inhibitor p27 and its deregulation in cancer. J. Cell Physiol. 183: 10-17
99. Smith, W. L. (1989) The eicosanoids and their biochemical mechanisms of action. Biochem. J. 259: 315-324
100. Soncin, F., Calderwood, S. K. (1996) Reciprocal effects of pro-inflammatory stimuli and anti-inflammatory drugs on the activity of heat shock factor-1 in human monocytes. Biochem. Biophys. Res. Commun. 229: 479-484
101. Steegenga, W. T., van der Eb, A. J., Jochemsen, A. G. (1996) How phosphorylation regulates the activity of p53. J. Mol. Biol. 263: 103-113
102. Stoner, G. D., Budd, G. T., Ganapathi, R., DeYoung, B., Kresty, L. A., Nitert, M., Fryer, B., Church, J. M., Provencher, K., Pamukcu, R., Piazza, G., Hawk, E., Kelloff, G., Elson, P., van Stolk, R. U. (1999) Sulindac sulfone induced regression of rectal polyps in patients with familial adenomatous polyposis. Adv. Exp. Med. Biol. 470: 45-53
103. Strassmann, G., Patil-Koota, V., Finkelman, F., Fong, M., Kambayashi, T. (1994) Evidence for the involvement of interleukin 10 in the differential deactivation of murine peritoneal macrophages by prostaglandin E2. J. Exp. Med. 180: 2365-2370
104. Takeuchi, K., Takahashi, N., Abe, T., Ito, O., Tsutsumi, E., Taniyama, Y., Abe, K. (1994) Functional difference between two isoforms of rat kidney prostaglandin receptor EP3 subtype. Biochem. Biophys. Res. Commun. 203: 1897-1903
105. Thompson, W. J., Piazza, G. A., Li, H., Liu, L., Fetter, J., Zhu, B., Sperl, G., Ahnen, D., Pamukcu, R. (2000) Exisulind induction of apoptosis involves guanosine 3′,5′-cyclic monophosphate phosphodiesterase inhibition, protein kinase G activation, and attenuated beta-catenin. Cancer Res. 60: 3338-3342
106. Tonelli, F., Valanzano, R., Messerini, L., Ficari, F. (2000) Long-term treatment with sulindac in familial adenomatous polyposis: is there an actual efficacy in prevention of rectal cancer? J. Surg. Oncol. 74: 15-20
107. Tonnesen, M. G., Feng, X., Clark, R. A. (2000) Angiogenesis in wound healing. J. Invest. Dermatol. Symp. Proc. 5: 40-46
108. Uyemura, S. A., Santos, A. C., Mingatto, F. E., Jordani, M. C., Curti, C. (1997) Diclofenac sodium and mefenamic acid: potent inducers of the membrane permeability transition in renal cortex mitochondria. Arch. Biochem. Biophys. 342: 231-235
109. Walden, T. L., Patchen, M., Snyder, S. L. (1987) 16,16-Dimethyl prostaglandin E2 increases survival in mice following irradiation. Radiat. Res. 109: 440-448
110. Wasil, M., Halliwell, B., Moorhouse, C. P., Hutchison, D. C., Baum, H. (1987) Biologically-significant scavenging of the myeloperoxidase-derived oxidant hypochlorous acid by some anti-inflammatory drugs. Biochem. Pharmacol. 36: 3847-3850
111. Watters, D. (1999) Molecular mechanisms of ionizing radiation-induced apoptosis. Immunol. Cell Biol. 77: 263-271
112. Weiss, J. F., Landauer, M. R. (2000) Radioprotection by antioxidants. Ann. NY Acad. Sci. 899: 44-60
113. Wenzel, S. E. (1997) Arachidonic acid metabolites: mediators of inflammation in asthma. Pharmacotherapy 17: 3S-12S
114. Worthington, H. V., Clarkson, J. E., Eden, O. B. (2002) Interventions for treating oral mucositis for patients with cancer receiving treatment (Cochrane Review). Cochrane Database Syst. Rev. CD001973
115. Wu, L. J., Randers-Pehrson, G., Xu, A., Waldren, C. A., Geard, C. R., Yu, Z., Hei, T. K. (1999) Targeted cytoplasmic irradiation with alpha particles induces mutations in mammalian cells. Proc. Natl Acad. Sci. USA 96: 4959-4964
116. Zhou, H., Randers-Pehrson, G., Waldren, C. A., Vannais, D., Hall, E. J., Hei, T. K. (2000) Induction of a bystander mutagenic effect of alpha particles in mammalian cells. Proc. Natl Acad. Sci. USA 97: 2099-2104